|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Procainamide#Package and Label Display Panel]] |
| {{Procainamide}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Labels and Packages==
| |
| | |
| {|
| |
| |[[File:Procainamide05.jpg|thumb|600px]]
| |
| |}
| |
| | |
| {|
| |
| |[[File:Procainamide06.jpg|thumb|600px]]
| |
| |}
| |
| | |
| {|
| |
| |[[File:Procainamide07.jpg|thumb|600px]]
| |
| |}
| |
| | |
| {|
| |
| |[[File:Procainamide08.jpg|thumb|600px]]
| |
| |}<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PROCAINAMIDE HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17e47845-daad-434c-a784-6d3875b0d704 | publisher = | date = | accessdate = 11 March 2014 }}</ref>
| |
| ==References==
| |
| {{Reflist}}
| |
| | |
| [[Category:Benzamides]]
| |
| [[Category:Anilines]]
| |
| [[Category:Sodium channel blockers]]
| |
| [[Category:Antiarrhythmic agents]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |